SIMILAR PATTERNS OF AMINO ACIDS FOR 3OHT_B_1N1B1000_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1cm8 | PHOSPHORYLATED MAPKINASE P38-GAMMA (Homo sapiens) |
PF00069(Pkinase) | 6 | VAL A 41ALA A 54LEU A 78ILE A 87GLY A 113LEU A 170 | ANP A 400 (-4.1A)ANP A 400 (-3.3A)NoneANP A 400 (-4.9A)NoneANP A 400 (-4.0A) | 0.80A | 3ohtB-1cm8A:6.2 | 3ohtB-1cm8A:58.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1cm8 | PHOSPHORYLATED MAPKINASE P38-GAMMA (Homo sapiens) |
PF00069(Pkinase) | 6 | VAL A 41ALA A 54LYS A 56LEU A 78ILE A 87GLY A 113 | ANP A 400 (-4.1A)ANP A 400 (-3.3A)ANP A 400 (-2.9A)NoneANP A 400 (-4.9A)None | 0.66A | 3ohtB-1cm8A:6.2 | 3ohtB-1cm8A:58.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k9a | CARBOXYL-TERMINALSRC KINASE (Rattusnorvegicus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 6 | GLY A 202VAL A 209ALA A 220LYS A 222THR A 266GLY A 272 | None | 0.91A | 3ohtB-1k9aA:16.9 | 3ohtB-1k9aA:23.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k9a | CARBOXYL-TERMINALSRC KINASE (Rattusnorvegicus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 6 | GLY A 202VAL A 209ALA A 220LYS A 222THR A 266LEU A 321 | None | 0.91A | 3ohtB-1k9aA:16.9 | 3ohtB-1k9aA:23.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q8y | SR PROTEIN KINASE (Saccharomycescerevisiae) |
PF00069(Pkinase) | 6 | GLY A 165VAL A 172ALA A 185LYS A 187GLY A 250LEU A 226 | ADP A 810 (-3.3A)ADP A 810 (-4.1A)ADP A 810 (-3.3A)ADP A 810 (-3.1A)NoneADP A 810 (-4.4A) | 1.15A | 3ohtB-1q8yA:5.7 | 3ohtB-1q8yA:27.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q8y | SR PROTEIN KINASE (Saccharomycescerevisiae) |
PF00069(Pkinase) | 6 | GLY A 165VAL A 172LYS A 187LEU A 206GLY A 250LEU A 226 | ADP A 810 (-3.3A)ADP A 810 (-4.1A)ADP A 810 (-3.1A)NoneNoneADP A 810 (-4.4A) | 1.27A | 3ohtB-1q8yA:5.7 | 3ohtB-1q8yA:27.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t46 | HOMO SAPIENS V-KITHARDY-ZUCKERMAN 4FELINE SARCOMA VIRALONCOGENE HOMOLOG (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | GLY A 596VAL A 603ALA A 621LYS A 623LEU A 644THR A 670GLY A 676 | NoneSTI A 3 ( 4.6A)STI A 3 (-3.5A)STI A 3 (-3.7A)STI A 3 (-4.4A)STI A 3 (-3.2A)STI A 3 ( 3.8A) | 0.70A | 3ohtB-1t46A:16.2 | 3ohtB-1t46A:25.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1u5q | SERINE/THREONINEPROTEIN KINASE TAO2 (Rattusnorvegicus) |
PF00069(Pkinase) | 5 | GLY A 35VAL A 42ALA A 55LYS A 57ILE A 89 | None | 0.54A | 3ohtB-1u5qA:17.8 | 3ohtB-1u5qA:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zws | DAP-KINASE RELATEDPROTEIN 1 (Homo sapiens) |
PF00069(Pkinase) | 5 | GLY A 20VAL A 27ALA A 40LEU A 68ILE A 77 | None | 0.50A | 3ohtB-1zwsA:6.4 | 3ohtB-1zwsA:28.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dq7 | PROTO-ONCOGENETYROSINE-PROTEINKINASE FYN (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY X 18VAL X 25ALA X 37LYS X 39THR X 82GLY X 88 | STU X 902 ( 3.7A)STU X 902 ( 4.8A)STU X 902 (-3.1A)STU X 902 (-3.1A)STU X 902 (-4.1A)STU X 902 (-3.5A) | 0.82A | 3ohtB-2dq7X:17.3 | 3ohtB-2dq7X:27.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f9g | MITOGEN-ACTIVATEDPROTEIN KINASE FUS3 (Saccharomycescerevisiae) |
PF00069(Pkinase) | 6 | GLY A 20VAL A 27ALA A 40LYS A 42ILE A 72LEU A 144 | ADP A 500 ( 4.1A)ADP A 500 (-4.3A)ADP A 500 ( 3.7A)ADP A 500 (-2.9A)NoneADP A 500 (-4.3A) | 1.00A | 3ohtB-2f9gA:28.7 | 3ohtB-2f9gA:41.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f9g | MITOGEN-ACTIVATEDPROTEIN KINASE FUS3 (Saccharomycescerevisiae) |
PF00069(Pkinase) | 6 | GLY A 20VAL A 27ALA A 40LYS A 42LEU A 63ILE A 72 | ADP A 500 ( 4.1A)ADP A 500 (-4.3A)ADP A 500 ( 3.7A)ADP A 500 (-2.9A)NoneNone | 0.68A | 3ohtB-2f9gA:28.7 | 3ohtB-2f9gA:41.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gcd | SERINE/THREONINE-PROTEIN KINASE TAO2 (Rattusnorvegicus) |
PF00069(Pkinase) | 6 | GLY A 35VAL A 42ALA A 55LYS A 57LEU A 80GLY A 110 | STU A 400 (-3.3A)STU A 400 ( 4.8A)STU A 400 (-3.2A)STU A 400 ( 4.5A)NoneSTU A 400 (-3.4A) | 0.64A | 3ohtB-2gcdA:18.4 | 3ohtB-2gcdA:24.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hen | EPHRIN TYPE-BRECEPTOR 2 (Mus musculus) |
PF07714(Pkinase_Tyr) | 6 | GLY A 636VAL A 643ALA A 659ILE A 691THR A 707LEU A 761 | ADP A 400 ( 3.9A)ADP A 400 ( 4.4A)ADP A 400 (-3.2A)NoneADP A 400 (-4.7A)ADP A 400 ( 4.7A) | 0.94A | 3ohtB-2henA:17.4 | 3ohtB-2henA:23.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hk5 | TYROSINE-PROTEINKINASE HCK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 252VAL A 259ALA A 271LYS A 273THR A 316LEU A 371 | None1BM A 499 ( 4.8A)1BM A 499 (-3.6A)1BM A 499 (-3.8A)1BM A 499 (-3.2A)1BM A 499 (-4.4A) | 0.84A | 3ohtB-2hk5A:17.1 | 3ohtB-2hk5A:24.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hz0 | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 249VAL A 256ALA A 269LYS A 271THR A 315GLY A 321 | NoneGIN A 600 ( 4.7A)GIN A 600 (-3.1A)GIN A 600 (-3.6A)GIN A 600 (-3.4A)None | 0.71A | 3ohtB-2hz0A:16.6 | 3ohtB-2hz0A:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i0e | PROTEIN KINASEC-BETA II (Homo sapiens) |
PF00069(Pkinase)PF00433(Pkinase_C) | 5 | GLY A 349VAL A 356ALA A 369LYS A 371LEU A 394 | PDS A 901 ( 3.7A)PDS A 901 (-4.2A)PDS A 901 (-3.3A)PDS A 901 ( 4.5A)None | 0.42A | 3ohtB-2i0eA:4.8 | 3ohtB-2i0eA:25.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2phk | PHOSPHORYLASE KINASE (Oryctolaguscuniculus) |
PF00069(Pkinase) | 6 | GLY A 26VAL A 33ALA A 46LYS A 48ILE A 87GLY A 109 | ATP A 381 (-3.5A)ATP A 381 (-4.1A)ATP A 381 (-3.5A)ATP A 381 (-3.2A)NoneNone | 0.87A | 3ohtB-2phkA:18.1 | 3ohtB-2phkA:30.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2phk | PHOSPHORYLASE KINASE (Oryctolaguscuniculus) |
PF00069(Pkinase) | 6 | GLY A 26VAL A 33LYS A 48LEU A 77ILE A 87GLY A 109 | ATP A 381 (-3.5A)ATP A 381 (-4.1A)ATP A 381 (-3.2A)NoneNoneNone | 0.93A | 3ohtB-2phkA:18.1 | 3ohtB-2phkA:30.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qr7 | RIBOSOMAL PROTEIN S6KINASE ALPHA-3 (Mus musculus) |
PF00069(Pkinase) | 6 | GLY A 429ALA A 449LYS A 451LEU A 467ILE A 477THR A 493 | None | 0.58A | 3ohtB-2qr7A:5.4 | 3ohtB-2qr7A:28.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r2p | EPHRIN TYPE-ARECEPTOR 5 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 6 | GLY A 682VAL A 689ALA A 705ILE A 737THR A 753GLY A 759 | None | 1.15A | 3ohtB-2r2pA:17.5 | 3ohtB-2r2pA:22.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w4k | DEATH-ASSOCIATEDPROTEIN KINASE 1 (Homo sapiens) |
PF00069(Pkinase) | 5 | GLY A 20VAL A 27ALA A 40LYS A 42LEU A 68 | ADP A1303 (-3.4A)ADP A1303 (-4.0A)ADP A1303 (-3.5A)ADP A1303 (-2.7A)None | 0.50A | 3ohtB-2w4kA:5.0 | 3ohtB-2w4kA:27.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wtk | SERINE/THREONINE-PROTEIN KINASE 11 (Homo sapiens) |
PF00069(Pkinase) | 5 | GLY C 56VAL C 63ALA C 76LYS C 78ILE C 111 | ANP C 2 (-3.3A)ANP C 2 (-4.2A)ANP C 2 (-3.4A)ANP C 2 (-3.6A)None | 0.53A | 3ohtB-2wtkC:18.0 | 3ohtB-2wtkC:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wtk | SERINE/THREONINE-PROTEIN KINASE 11 (Homo sapiens) |
PF00069(Pkinase) | 6 | GLY C 56VAL C 63LYS C 78LEU C 102ILE C 111GLY C 135 | ANP C 2 (-3.3A)ANP C 2 (-4.2A)ANP C 2 (-3.6A)NoneNoneNone | 1.42A | 3ohtB-2wtkC:18.0 | 3ohtB-2wtkC:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xyu | EPHRIN TYPE-ARECEPTOR 4, (Mus musculus) |
PF07714(Pkinase_Tyr) | 7 | GLY A 628VAL A 635ALA A 651LYS A 653ILE A 683THR A 699LEU A 753 | NoneQ9G A1898 ( 4.7A)Q9G A1898 (-3.2A)Q9G A1898 (-4.8A)Q9G A1898 ( 4.9A)Q9G A1898 (-3.5A)Q9G A1898 (-4.3A) | 0.92A | 3ohtB-2xyuA:6.0 | 3ohtB-2xyuA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xyu | EPHRIN TYPE-ARECEPTOR 4, (Mus musculus) |
PF07714(Pkinase_Tyr) | 6 | GLY A 628VAL A 635ALA A 651LYS A 653THR A 699GLY A 705 | NoneQ9G A1898 ( 4.7A)Q9G A1898 (-3.2A)Q9G A1898 (-4.8A)Q9G A1898 (-3.5A)Q9G A1898 ( 3.8A) | 0.79A | 3ohtB-2xyuA:6.0 | 3ohtB-2xyuA:23.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y7j | PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM (Homo sapiens) |
PF00069(Pkinase) | 6 | GLY A 31VAL A 38ALA A 51LYS A 53LEU A 81GLY A 113 | B49 A1294 (-4.0A)NoneB49 A1294 (-3.2A)NoneNoneB49 A1294 (-3.6A) | 0.91A | 3ohtB-2y7jA:19.5 | 3ohtB-2y7jA:25.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2y7j | PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM (Homo sapiens) |
PF00069(Pkinase) | 6 | VAL A 38ALA A 51LYS A 53LEU A 81ILE A 91GLY A 113 | NoneB49 A1294 (-3.2A)NoneNoneB49 A1294 ( 4.6A)B49 A1294 (-3.6A) | 0.94A | 3ohtB-2y7jA:19.5 | 3ohtB-2y7jA:25.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yab | DEATH-ASSOCIATEDPROTEIN KINASE 2 (Mus musculus) |
PF00069(Pkinase) | 5 | GLY A 20VAL A 27ALA A 40LYS A 42LEU A 68 | AMP A1302 (-3.5A)AMP A1302 (-4.2A)AMP A1302 (-3.6A)AMP A1302 (-2.8A)None | 0.46A | 3ohtB-2yabA:5.5 | 3ohtB-2yabA:27.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bqr | DEATH-ASSOCIATEDPROTEIN KINASE 3 (Homo sapiens) |
PF00069(Pkinase) | 6 | GLY A 20VAL A 27ALA A 40LYS A 42LEU A 68ILE A 77 | 4RB A 401 (-3.6A)4RB A 401 ( 4.4A)4RB A 401 (-3.3A)4RB A 401 ( 2.8A)None4RB A 401 ( 4.3A) | 0.61A | 3ohtB-3bqrA:18.6 | 3ohtB-3bqrA:25.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3coi | MITOGEN-ACTIVATEDPROTEIN KINASE 13 (Homo sapiens) |
PF00069(Pkinase) | 6 | GLY A 32VAL A 39ALA A 52LEU A 76ILE A 85LEU A 167 | None | 0.43A | 3ohtB-3coiA:32.6 | 3ohtB-3coiA:58.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d7u | TYROSINE-PROTEINKINASE CSK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 202VAL A 209ALA A 220LYS A 222THR A 266GLY A 272 | None | 0.91A | 3ohtB-3d7uA:5.5 | 3ohtB-3d7uA:23.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d7u | TYROSINE-PROTEINKINASE CSK (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 202VAL A 209ALA A 220LYS A 222THR A 266LEU A 321 | None | 0.91A | 3ohtB-3d7uA:5.5 | 3ohtB-3d7uA:23.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dtc | MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE 9 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 151VAL A 158ALA A 169LYS A 171ILE A 204GLY A 226 | VIN A6331 (-3.5A)VIN A6331 (-4.7A)VIN A6331 (-3.4A)NoneVIN A6331 ( 4.9A)VIN A6331 (-3.4A) | 0.93A | 3ohtB-3dtcA:5.1 | 3ohtB-3dtcA:25.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3e7o | MITOGEN-ACTIVATEDPROTEIN KINASE 9 (Homo sapiens) |
PF00069(Pkinase) | 5 | GLY A 33VAL A 40ALA A 53LYS A 55LEU A 77 | 35F A 1 ( 4.8A)35F A 1 ( 4.8A)35F A 1 (-3.6A)35F A 1 ( 4.6A)None | 0.53A | 3ohtB-3e7oA:8.1 | 3ohtB-3e7oA:46.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f2a | PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE PIM-1 (Homo sapiens) |
PF00069(Pkinase) | 6 | GLY A 45VAL A 52ALA A 65LYS A 67LEU A 93ILE A 104 | 985 A 1 ( 3.9A)985 A 1 (-4.5A)985 A 1 (-3.5A)985 A 1 ( 2.8A) MG A 314 ( 4.8A)985 A 1 ( 4.7A) | 0.69A | 3ohtB-3f2aA:5.1 | 3ohtB-3f2aA:23.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gp0 | MITOGEN-ACTIVATEDPROTEIN KINASE 11 (Homo sapiens) |
PF00069(Pkinase) | 7 | GLY A 31VAL A 38ALA A 51LEU A 75ILE A 84THR A 106ASN A 114 | NoneNIL A 1 ( 4.7A)NIL A 1 (-3.7A)NIL A 1 ( 4.8A)NIL A 1 (-4.4A)NIL A 1 (-3.3A)None | 1.20A | 3ohtB-3gp0A:32.9 | 3ohtB-3gp0A:68.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gp0 | MITOGEN-ACTIVATEDPROTEIN KINASE 11 (Homo sapiens) |
PF00069(Pkinase) | 7 | GLY A 31VAL A 38ALA A 51LEU A 75ILE A 84THR A 106LEU A 167 | NoneNIL A 1 ( 4.7A)NIL A 1 (-3.7A)NIL A 1 ( 4.8A)NIL A 1 (-4.4A)NIL A 1 (-3.3A)NIL A 1 (-4.0A) | 0.73A | 3ohtB-3gp0A:32.9 | 3ohtB-3gp0A:68.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gp0 | MITOGEN-ACTIVATEDPROTEIN KINASE 11 (Homo sapiens) |
PF00069(Pkinase) | 8 | GLY A 31VAL A 38ALA A 51LYS A 53ILE A 84THR A 106ASN A 115LEU A 167 | NoneNIL A 1 ( 4.7A)NIL A 1 (-3.7A)NoneNIL A 1 (-4.4A)NIL A 1 (-3.3A)NoneNIL A 1 (-4.0A) | 1.02A | 3ohtB-3gp0A:32.9 | 3ohtB-3gp0A:68.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kul | EPHRIN TYPE-ARECEPTOR 8 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 6 | VAL A 649ALA A 665LYS A 667ILE A 697THR A 713GLY A 719 | NoneNoneNoneNoneNoneGOL A 403 (-3.4A) | 0.89A | 3ohtB-3kulA:17.0 | 3ohtB-3kulA:26.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lj0 | SERINE/THREONINE-PROTEINKINASE/ENDORIBONUCLEASE IRE1 (Saccharomycescerevisiae) |
PF00069(Pkinase)PF06479(Ribonuc_2-5A) | 6 | GLY A 681VAL A 689ALA A 700LYS A 702LEU A 719ILE A 729 | ADP A2101 (-3.6A)ADP A2101 (-4.5A)ADP A2101 (-3.5A)ADP A2101 (-2.7A)NoneNone | 0.68A | 3ohtB-3lj0A:3.2 | 3ohtB-3lj0A:27.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3llt | SERINE/THREONINEKINASE-1, PFLAMMER (Plasmodiumfalciparum) |
PF00069(Pkinase) | 6 | GLY A 559VAL A 566ALA A 579LYS A 581LEU A 600GLY A 634 | ANP A 877 (-3.8A)ANP A 877 (-4.1A)ANP A 877 ( 3.7A)ANP A 877 (-2.7A)NoneNone | 0.61A | 3ohtB-3lltA:5.3 | 3ohtB-3lltA:26.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lm5 | SERINE/THREONINE-PROTEIN KINASE 17B (Homo sapiens) |
PF00069(Pkinase) | 5 | GLY A 40VAL A 47ALA A 60LEU A 84ILE A 94 | NoneQUE A 1 ( 4.6A)QUE A 1 (-3.2A)QUE A 1 ( 4.6A)QUE A 1 (-4.6A) | 0.51A | 3ohtB-3lm5A:6.9 | 3ohtB-3lm5A:29.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mdy | BONE MORPHOGENETICPROTEIN RECEPTORTYPE-1B (Homo sapiens) |
PF07714(Pkinase_Tyr)PF08515(TGF_beta_GS) | 5 | GLY A 211VAL A 218ALA A 229LYS A 231THR A 279 | LDN A 1 ( 4.7A)LDN A 1 ( 4.8A)LDN A 1 (-3.6A)NoneLDN A 1 (-3.8A) | 0.50A | 3ohtB-3mdyA:15.4 | 3ohtB-3mdyA:24.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mvj | CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA (Homo sapiens) |
PF00069(Pkinase) | 5 | GLY A 50VAL A 57ALA A 70LYS A 72LEU A 95 | XFE A 351 ( 4.0A)XFE A 351 ( 4.5A)XFE A 351 (-3.2A)NoneNone | 0.49A | 3ohtB-3mvjA:5.3 | 3ohtB-3mvjA:28.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3my0 | SERINE/THREONINE-PROTEIN KINASE RECEPTORR3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 209VAL A 216ALA A 227LYS A 229THR A 277LEU A 337 | NoneLDN A 600 (-4.5A)LDN A 600 (-3.2A)LDN A 600 (-4.0A)LDN A 600 (-4.0A)LDN A 600 (-4.6A) | 0.88A | 3ohtB-3my0A:4.5 | 3ohtB-3my0A:24.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n9x | PHOSPHOTRANSFERASE (Plasmodiumberghei) |
PF00069(Pkinase) | 6 | GLY A 35VAL A 42ALA A 55LYS A 57LEU A 79ILE A 88 | NoneNoneGOL A 434 ( 4.1A)GOL A 433 (-3.2A)NoneNone | 0.63A | 3ohtB-3n9xA:26.2 | 3ohtB-3n9xA:32.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nie | MAP2 KINASE (Plasmodiumfalciparum) |
PF00069(Pkinase) | 5 | GLY A 37VAL A 44ALA A 57LYS A 59LEU A 81 | ANP A 430 (-3.5A)ANP A 430 (-4.2A)ANP A 430 (-3.5A)ANP A 430 (-2.5A)None | 0.52A | 3ohtB-3nieA:26.9 | 3ohtB-3nieA:32.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3nie | MAP2 KINASE (Plasmodiumfalciparum) |
PF00069(Pkinase) | 5 | VAL A 44ALA A 57LYS A 59LEU A 81ILE A 90 | ANP A 430 (-4.2A)ANP A 430 (-3.5A)ANP A 430 (-2.5A)NoneANP A 430 ( 4.5A) | 0.48A | 3ohtB-3nieA:26.9 | 3ohtB-3nieA:32.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pg1 | MITOGEN-ACTIVATEDPROTEIN KINASE,PUTATIVE (MAPKINASE-LIKE PROTEIN) (Leishmaniamajor) |
PF00069(Pkinase) | 5 | VAL A 37ALA A 49LYS A 51LEU A 82THR A 112 | None | 0.42A | 3ohtB-3pg1A:7.3 | 3ohtB-3pg1A:35.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pp0 | RECEPTORTYROSINE-PROTEINKINASE ERBB-2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 727VAL A 734ALA A 751LYS A 753THR A 798GLY A 804 | None03Q A 1 (-4.5A)03Q A 1 (-3.1A)03Q A 1 (-4.7A)03Q A 1 (-4.1A)03Q A 1 ( 3.9A) | 0.75A | 3ohtB-3pp0A:3.0 | 3ohtB-3pp0A:25.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pp0 | RECEPTORTYROSINE-PROTEINKINASE ERBB-2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 727VAL A 734ALA A 751LYS A 753THR A 798LEU A 852 | None03Q A 1 (-4.5A)03Q A 1 (-3.1A)03Q A 1 (-4.7A)03Q A 1 (-4.1A)03Q A 1 (-4.4A) | 0.94A | 3ohtB-3pp0A:3.0 | 3ohtB-3pp0A:25.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ppz | SERINE/THREONINE-PROTEIN KINASE CTR1 (Arabidopsisthaliana) |
PF07714(Pkinase_Tyr) | 6 | GLY A 558VAL A 565ALA A 576LYS A 578THR A 625GLY A 631 | STU A 1 (-3.2A)STU A 1 (-4.9A)STU A 1 (-3.3A)STU A 1 (-3.5A)STU A 1 (-4.1A)STU A 1 (-3.2A) | 0.90A | 3ohtB-3ppzA:17.1 | 3ohtB-3ppzA:26.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q5i | PROTEIN KINASE (Plasmodiumberghei) |
PF00069(Pkinase)PF13499(EF-hand_7) | 6 | GLY A 64VAL A 71ALA A 84LEU A 119ILE A 128THR A 144 | ANP A1634 ( 4.1A)ANP A1634 (-4.1A)ANP A1634 (-3.6A)NoneNoneANP A1634 (-4.6A) | 0.46A | 3ohtB-3q5iA:3.9 | 3ohtB-3q5iA:27.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3txo | PROTEIN KINASE C ETATYPE (Homo sapiens) |
PF00069(Pkinase)PF00433(Pkinase_C) | 5 | GLY A 362VAL A 369ALA A 382LYS A 384LEU A 407 | 07U A 1 ( 4.2A)07U A 1 (-4.8A)07U A 1 (-3.3A)07U A 1 (-3.0A)None | 0.51A | 3ohtB-3txoA:5.1 | 3ohtB-3txoA:24.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zfx | EPHRIN TYPE-BRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 626VAL A 633ALA A 649ILE A 681THR A 697GLY A 703 | None | 0.84A | 3ohtB-3zfxA:16.9 | 3ohtB-3zfxA:27.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zfx | EPHRIN TYPE-BRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 626VAL A 633ALA A 649ILE A 681THR A 697LEU A 751 | None | 0.95A | 3ohtB-3zfxA:16.9 | 3ohtB-3zfxA:27.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4aw5 | EPHRIN TYPE-BRECEPTOR 4 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 98VAL A 105ALA A 121ILE A 153THR A 169GLY A 175 | 30K A1365 ( 3.9A)30K A1365 ( 4.6A)30K A1365 (-3.2A)None30K A1365 (-3.8A)30K A1365 (-3.5A) | 0.97A | 3ohtB-4aw5A:17.5 | 3ohtB-4aw5A:25.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4aw5 | EPHRIN TYPE-BRECEPTOR 4 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 98VAL A 105ALA A 121ILE A 153THR A 169LEU A 223 | 30K A1365 ( 3.9A)30K A1365 ( 4.6A)30K A1365 (-3.2A)None30K A1365 (-3.8A)30K A1365 (-4.5A) | 0.98A | 3ohtB-4aw5A:17.5 | 3ohtB-4aw5A:25.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4aw5 | EPHRIN TYPE-BRECEPTOR 4 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 98VAL A 105ALA A 121LYS A 123ILE A 153LEU A 223 | 30K A1365 ( 3.9A)30K A1365 ( 4.6A)30K A1365 (-3.2A)30K A1365 (-3.8A)None30K A1365 (-4.5A) | 1.01A | 3ohtB-4aw5A:17.5 | 3ohtB-4aw5A:25.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c02 | ACTIVIN RECEPTORTYPE-1 (Homo sapiens) |
PF00069(Pkinase)PF08515(TGF_beta_GS) | 6 | GLY A 215VAL A 222ALA A 233LYS A 235THR A 283LEU A 343 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)TAK A1507 (-3.6A)TAK A1507 (-4.7A) | 0.84A | 3ohtB-4c02A:4.5 | 3ohtB-4c02A:26.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c0t | LIKELY PROTEINKINASE (Candidaalbicans) |
PF00069(Pkinase) | 6 | GLY A 247VAL A 254ALA A 267LYS A 269LEU A 292ILE A 302 | None | 0.71A | 3ohtB-4c0tA:5.6 | 3ohtB-4c0tA:17.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ckr | EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 617VAL A 624ALA A 653LYS A 655ILE A 685THR A 701 | NoneDI1 A1000 (-4.8A)DI1 A1000 (-3.6A)DI1 A1000 (-3.9A)DI1 A1000 (-4.5A)DI1 A1000 (-3.6A) | 0.46A | 3ohtB-4ckrA:16.9 | 3ohtB-4ckrA:25.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4euu | SERINE/THREONINE-PROTEIN KINASE TBK1 (Homo sapiens) |
PF00069(Pkinase) | 6 | GLY A 16VAL A 23ALA A 36LYS A 38LEU A 59GLY A 92 | BX7 A 401 ( 3.8A)BX7 A 401 ( 4.6A)BX7 A 401 (-3.4A)BX7 A 401 (-3.5A)NoneBX7 A 401 (-3.3A) | 0.84A | 3ohtB-4euuA:2.5 | 3ohtB-4euuA:24.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hvi | TYROSINE-PROTEINKINASE JAK3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 829VAL A 836ALA A 853LYS A 855LEU A 875GLY A 908 | 19S A1201 (-3.7A)19S A1201 (-4.4A)19S A1201 (-3.3A)19S A1201 (-3.5A)None19S A1201 ( 3.8A) | 0.86A | 3ohtB-4hviA:16.8 | 3ohtB-4hviA:23.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hzs | ACTIVATED CDC42KINASE 1 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14604(SH3_9) | 5 | GLY A 133VAL A 140ALA A 156THR A 205GLY A 211 | None | 0.53A | 3ohtB-4hzsA:4.9 | 3ohtB-4hzsA:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4id7 | ACTIVATED CDC42KINASE 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 133VAL A 140ALA A 156ILE A 190THR A 205GLY A 211 | 1G0 A 401 ( 4.2A)1G0 A 401 (-4.4A)1G0 A 401 (-3.6A)1G0 A 401 (-4.3A)1G0 A 401 (-3.2A)1G0 A 401 ( 4.5A) | 1.12A | 3ohtB-4id7A:3.2 | 3ohtB-4id7A:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4id7 | ACTIVATED CDC42KINASE 1 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 133VAL A 140ALA A 156LYS A 158ILE A 190THR A 205 | 1G0 A 401 ( 4.2A)1G0 A 401 (-4.4A)1G0 A 401 (-3.6A)1G0 A 401 (-3.7A)1G0 A 401 (-4.3A)1G0 A 401 (-3.2A) | 0.68A | 3ohtB-4id7A:3.2 | 3ohtB-4id7A:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k33 | FIBROBLAST GROWTHFACTOR RECEPTOR 3 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | GLY A 479VAL A 486ALA A 506LYS A 508ILE A 539 | ACP A 801 (-3.4A)ACP A 801 (-4.2A)ACP A 801 (-3.3A)ACP A 801 (-2.7A)None | 0.51A | 3ohtB-4k33A:5.4 | 3ohtB-4k33A:27.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o27 | SERINE/THREONINE-PROTEIN KINASE 24 (Homo sapiens) |
PF00069(Pkinase) | 6 | GLY B 31VAL B 38ALA B 51LYS B 53LEU B 74GLY B 103 | ADP B 500 ( 3.8A)ADP B 500 (-4.5A)ADP B 500 (-3.3A)ADP B 500 (-3.1A)NoneNone | 0.73A | 3ohtB-4o27B:5.9 | 3ohtB-4o27B:24.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p2k | EPHRIN TYPE-ARECEPTOR 2 (Homo sapiens) |
PF07714(Pkinase_Tyr)PF14575(EphA2_TM) | 6 | GLY A 620VAL A 627ALA A 644ILE A 676THR A 692LEU A 746 | None | 0.96A | 3ohtB-4p2kA:6.1 | 3ohtB-4p2kA:25.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qny | MITOGEN ACTIVATEDPROTEIN KINASE,PUTATIVE (Leishmaniadonovani) |
PF00069(Pkinase) | 5 | VAL A 35ALA A 49LYS A 51LEU A 74ILE A 83 | ANP A 402 (-4.3A)ANP A 402 (-3.3A)ANP A 402 (-2.8A)NoneANP A 402 (-4.8A) | 0.47A | 3ohtB-4qnyA:9.0 | 3ohtB-4qnyA:38.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4tyh | MITOGEN-ACTIVATEDPROTEIN KINASE 14 (Mus musculus) |
PF00069(Pkinase) | 7 | GLY B 31VAL B 38ALA B 51LYS B 53ILE B 84THR B 106LEU B 167 | NoneNone39G B 401 (-3.5A)39G B 401 (-4.2A)39G B 401 ( 3.8A)39G B 401 (-3.6A)39G B 401 (-3.6A) | 0.77A | 3ohtB-4tyhB:34.3 | 3ohtB-4tyhB:86.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4tyh | MITOGEN-ACTIVATEDPROTEIN KINASE 14 (Mus musculus) |
PF00069(Pkinase) | 5 | VAL B 38ALA B 51LEU B 75ILE B 84LEU B 167 | None39G B 401 (-3.5A)39G B 401 (-4.3A)39G B 401 ( 3.8A)39G B 401 (-3.6A) | 0.45A | 3ohtB-4tyhB:34.3 | 3ohtB-4tyhB:86.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4tyh | MITOGEN-ACTIVATEDPROTEIN KINASE 14 (Mus musculus) |
PF00069(Pkinase) | 6 | VAL B 38ALA B 51LYS B 53ILE B 84THR B 106ASN B 115 | None39G B 401 (-3.5A)39G B 401 (-4.2A)39G B 401 ( 3.8A)39G B 401 (-3.6A)None | 0.85A | 3ohtB-4tyhB:34.3 | 3ohtB-4tyhB:86.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xi2 | TYROSINE-PROTEINKINASE BTK (Mus musculus) |
PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 5 | GLY A 409VAL A 416ALA A 428THR A 474ASP A 539 | None | 0.49A | 3ohtB-4xi2A:6.1 | 3ohtB-4xi2A:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y93 | NON-SPECIFICPROTEIN-TYROSINEKINASE,NON-SPECIFICPROTEIN-TYROSINEKINASE (Bos taurus) |
PF00169(PH)PF00779(BTK)PF07714(Pkinase_Tyr) | 5 | GLY A 409VAL A 416ALA A 428THR A 474ASP A 539 | 746 A 702 ( 3.5A)746 A 702 ( 4.3A)746 A 702 (-2.4A)746 A 702 (-3.7A)746 A 702 (-3.7A) | 0.53A | 3ohtB-4y93A:5.3 | 3ohtB-4y93A:22.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yff | SERINE/THREONINE-PROTEIN KINASE TNNI3K (Homo sapiens) |
PF07714(Pkinase_Tyr) | 7 | GLY A 470VAL A 477ALA A 488LYS A 490LEU A 513ILE A 522THR A 539 | 4CV A 801 ( 3.9A)None4CV A 801 (-3.5A)4CV A 801 (-3.9A)None4CV A 801 ( 4.2A)4CV A 801 (-2.8A) | 0.63A | 3ohtB-4yffA:5.9 | 3ohtB-4yffA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ysj | CALMODULIN-LIKEDOMAIN PROTEINKINASE (Eimeria tenella) |
PF00069(Pkinase)PF13499(EF-hand_7) | 6 | GLY A 35VAL A 42ALA A 55LYS A 57LEU A 80THR A 105 | ADP A 506 (-3.5A)ADP A 506 (-4.3A)ADP A 506 (-3.3A)ADP A 506 (-2.4A)NoneADP A 506 ( 4.6A) | 0.68A | 3ohtB-4ysjA:18.7 | 3ohtB-4ysjA:24.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5d7a | TRAF2 ANDNCK-INTERACTINGPROTEIN KINASE (Homo sapiens) |
PF00069(Pkinase) | 6 | GLY A 32VAL A 39ALA A 52LYS A 54LEU A 73GLY A 111 | GLY A 32 ( 0.0A)VAL A 39 (-0.6A)ALA A 52 (-0.0A)LYS A 54 ( 0.0A)LEU A 73 ( 0.6A)GLY A 111 (-0.0A) | 0.69A | 3ohtB-5d7aA:18.3 | 3ohtB-5d7aA:25.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e8y | TGF-BETA RECEPTORTYPE-2 (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 251VAL A 258ALA A 275LYS A 277THR A 325LEU A 386 | STU A 601 (-2.9A)STU A 601 (-4.0A)STU A 601 (-3.1A)STU A 601 (-2.4A)STU A 601 ( 3.7A)STU A 601 (-3.9A) | 0.96A | 3ohtB-5e8yA:4.6 | 3ohtB-5e8yA:24.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ezr | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE (Plasmodiumvivax) |
PF00027(cNMP_binding)PF00069(Pkinase) | 6 | GLY A 541VAL A 548ALA A 561LYS A 563ILE A 595THR A 611 | 4ZS A 901 ( 4.5A)4ZS A 901 (-4.8A)4ZS A 901 ( 3.8A)4ZS A 901 (-3.9A)4ZS A 901 (-4.3A)4ZS A 901 (-3.2A) | 0.42A | 3ohtB-5ezrA:4.9 | 3ohtB-5ezrA:18.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fd2 | SERINE/THREONINE-PROTEIN KINASE B-RAF (Homo sapiens) |
PF07714(Pkinase_Tyr) | 5 | GLY A 464VAL A 471ALA A 481LYS A 483THR A 529 | None5XJ A 801 (-4.6A)5XJ A 801 (-3.1A)5XJ A 801 (-3.8A)5XJ A 801 (-3.4A) | 0.50A | 3ohtB-5fd2A:17.1 | 3ohtB-5fd2A:26.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fm2 | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 731VAL A 738ALA A 756LEU A 779ILE A 788GLY A 810 | PP1 A2012 ( 3.9A)PP1 A2012 (-4.4A)PP1 A2012 (-3.2A)NoneNonePTR A 809 (-2.4A) | 0.85A | 3ohtB-5fm2A:16.5 | 3ohtB-5fm2A:24.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fm2 | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 731VAL A 738ALA A 756LYS A 758LEU A 779ILE A 788 | PP1 A2012 ( 3.9A)PP1 A2012 (-4.4A)PP1 A2012 (-3.2A)PP1 A2012 (-4.1A)NoneNone | 0.59A | 3ohtB-5fm2A:16.5 | 3ohtB-5fm2A:24.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5grn | PLATELET-DERIVEDGROWTH FACTORRECEPTOR ALPHA (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 600VAL A 607ALA A 625LYS A 627THR A 674GLY A 680 | None748 A1001 ( 4.7A)748 A1001 (-3.7A)748 A1001 (-4.0A)748 A1001 (-3.2A)748 A1001 ( 4.0A) | 0.76A | 3ohtB-5grnA:5.4 | 3ohtB-5grnA:26.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5grn | PLATELET-DERIVEDGROWTH FACTORRECEPTOR ALPHA (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | GLY A 600VAL A 607ALA A 625THR A 674GLY A 680ASN A 684 | None748 A1001 ( 4.7A)748 A1001 (-3.7A)748 A1001 (-3.2A)748 A1001 ( 4.0A)None | 0.81A | 3ohtB-5grnA:5.4 | 3ohtB-5grnA:26.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hes | MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT (Homo sapiens) |
PF07714(Pkinase_Tyr) | 6 | VAL A 30ALA A 43LYS A 45ILE A 66THR A 82GLY A 88 | 032 A 401 (-4.4A)032 A 401 (-3.2A)032 A 401 (-4.4A)032 A 401 (-4.4A)032 A 401 (-3.7A)032 A 401 ( 4.0A) | 0.88A | 3ohtB-5hesA:4.7 | 3ohtB-5hesA:27.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lxd | DUAL SPECIFICITYTYROSINE-PHOSPHORYLATION-REGULATEDKINASE 2 (Homo sapiens) |
PF00069(Pkinase) | 5 | GLY A 156VAL A 163ALA A 176LYS A 178ILE A 212 | 7A7 A 501 (-3.2A)7A7 A 501 (-4.4A)7A7 A 501 (-3.5A)7A7 A 501 (-3.5A)7A7 A 501 (-4.8A) | 0.46A | 3ohtB-5lxdA:8.8 | 3ohtB-5lxdA:27.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tvt | MATERNAL EMBRYONICLEUCINE ZIPPERKINASE (Homo sapiens) |
no annotation | 5 | GLY A 18VAL A 25ALA A 38LYS A 40LEU A 61 | 7LV A 401 ( 3.9A)7LV A 401 ( 4.6A)7LV A 401 (-3.4A)7LV A 401 (-3.0A)None | 0.52A | 3ohtB-5tvtA:6.4 | 3ohtB-5tvtA:23.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vcx | MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE (Homo sapiens) |
PF00069(Pkinase) | 5 | GLY A 117VAL A 124ALA A 137LYS A 139THR A 187 | H8H A 401 ( 3.7A)H8H A 401 (-4.7A)H8H A 401 (-3.3A)H8H A 401 (-4.9A)H8H A 401 (-3.5A) | 0.49A | 3ohtB-5vcxA:18.0 | 3ohtB-5vcxA:24.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wno | RECEPTORTYROSINE-PROTEINKINASE LET-23 (Caenorhabditiselegans) |
no annotation | 6 | GLY A 892VAL A 899ALA A 917LYS A 919THR A 963GLY A 969 | ANP A1201 ( 3.8A)ANP A1201 (-4.4A)ANP A1201 (-3.3A)ANP A1201 (-3.8A)ANP A1201 (-3.9A)ANP A1201 ( 4.6A) | 0.83A | 3ohtB-5wnoA:4.7 | 3ohtB-5wnoA:15.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wno | RECEPTORTYROSINE-PROTEINKINASE LET-23 (Caenorhabditiselegans) |
no annotation | 6 | GLY A 892VAL A 899ALA A 917LYS A 919THR A 963LEU A1017 | ANP A1201 ( 3.8A)ANP A1201 (-4.4A)ANP A1201 (-3.3A)ANP A1201 (-3.8A)ANP A1201 (-3.9A)ANP A1201 (-4.7A) | 0.99A | 3ohtB-5wnoA:4.7 | 3ohtB-5wnoA:15.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y86 | DUAL SPECIFICITYTYROSINE-PHOSPHORYLATION-REGULATEDKINASE 3 (Homo sapiens) |
no annotation | 5 | GLY A 216VAL A 223ALA A 236LYS A 238ILE A 272 | NoneHRM A 601 ( 4.9A)HRM A 601 (-3.5A)HRM A 601 (-3.3A)HRM A 601 ( 4.8A) | 0.51A | 3ohtB-5y86A:7.4 | 3ohtB-5y86A:11.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6b4w | DUAL SPECIFICITYPROTEIN KINASE TTK (Homo sapiens) |
no annotation | 6 | GLY A 532VAL A 539ALA A 551LYS A 553LEU A 575ILE A 586 | CQ7 A 801 ( 4.0A)CQ7 A 801 ( 4.8A)CQ7 A 801 (-3.2A)CQ7 A 801 (-3.2A)NoneCQ7 A 801 ( 4.5A) | 0.80A | 3ohtB-6b4wA:5.4 | 3ohtB-6b4wA:28.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cmj | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE KINASE 2 (Homo sapiens) |
no annotation | 6 | GLY A 172VAL A 179ALA A 192LYS A 194LEU A 240GLY A 273 | F6J A 501 ( 3.9A)F6J A 501 (-4.6A)F6J A 501 (-3.4A)F6J A 501 (-2.9A)NoneF6J A 501 ( 3.7A) | 0.75A | 3ohtB-6cmjA:6.5 | 3ohtB-6cmjA:11.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fek | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET (Homo sapiens) |
no annotation | 6 | GLY A 731VAL A 738ALA A 756LEU A 779ILE A 788GLY A 810 | ADN A1104 ( 3.9A)ADN A1104 (-4.4A)ADN A1104 (-3.4A)NoneADN A1104 ( 4.7A)ADN A1104 ( 3.8A) | 0.78A | 3ohtB-6fekA:16.6 | 3ohtB-6fekA:14.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fyl | DUAL SPECIFICITYPROTEIN KINASE CLK2 (Homo sapiens) |
no annotation | 6 | GLY A 170VAL A 177ALA A 191LYS A 193LEU A 212GLY A 247 | 3NG A 501 (-3.5A)3NG A 501 ( 4.4A)3NG A 501 (-3.3A)3NG A 501 (-3.0A)NoneNone | 0.72A | 3ohtB-6fylA:5.0 | 3ohtB-6fylA:undetectable |